Evidence map›Paper›PMID 32099512›Full record

ArticlePediatric health, medicine and therapeutics2019

Medication Utilization Patterns 90 Days Before Initiation of Treatment with Repository Corticotropin Injection in Patients with Infantile Spasms.

Laura S Gold, Tara A Nazareth, Tzy-Chyi Yu, Keith R Fry, Nancy Ho Mahler, Andrew Rava, Royce W Waltrip Ii, Ryan N Hansen

Open access · goldAbstract read
In one paragraph

Article in Pediatric health, medicine and therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Laura S GoldDepartment of Radiology, University of Washington, Seattle, WA, USA.
Tara A NazarethMallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
Tzy-Chyi YuMallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
Keith R FryMallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
Nancy Ho MahlerMallinckrodt Pharmaceuticals, Bedminster, NJ, USA.ORCID 0000-0003-4069-3617
Andrew RavaMallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
Royce W Waltrip IiMallinckrodt Pharmaceuticals, Bedminster, NJ, USA.
Ryan N HansenCHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA.
Mallinckrodt (United States) · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInfantile spasms (IS) is a rare and devastating form of early childhood epilepsy. Two drugs are approved in the United States for treatment of IS, H.P. Acthar MATERIALS AND

methodsTruven Health MarketScan

resultsThe 5 most common diagnoses other than IS observed in the study cohort (n=422) were "other convulsions," "acute upper respiratory infection," "esophageal reflux," "epilepsy, unspecified," and "abnormal involuntary muscle movements." Among the study cohort, 51.7% received RCI first; 38.9% received 1 drug class and 9.5% received >1 drug class before RCI initiation. Other AEDs were dispensed most often, either alone (31.3%) or with other drug classes (9.3%). Mean HCRU included 11.8 all-cause outpatient visits and 4.5 medications dispensed. Patients who received RCI or corticosteroids as their initial IS treatment had the lowest and second-lowest HCRU.

conclusionIn the 90 days before initiating RCI, patients with IS received multiple diagnoses and treatments, characterized by frequent HCRU. Use of RCI first (no prior IS medications) and AEDs first were associated with the lowest and highest HCRU, respectively, across all categories (all-cause outpatient visits, emergency department visits, hospital admissions, prescription medications).

Indexed as

early diagnosisearly treatmenthealth care resource utilizationInfantile spasmsmedication patterns

Identifiers

PMID32099512
PMCPMC6997416
OpenAlexW2997046287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.